- Home
- APLS vs VIRT Comparison
APLS vs VIRT Comparison
Compare APLS & VIRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | APLS | VIRT |
|---|---|---|
| Founded | 2009 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.2B | 4.8B |
| IPO Year | 2015 | 2014 |
Fundamental Metrics
Financial Performance| Metric | APLS | VIRT |
|---|---|---|
| Price | $41.05 | $52.06 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 21 | 5 |
| Target Price | $33.59 | ★ $45.60 |
| AVG Volume (30 Days) | ★ 8.3M | 1.2M |
| Earning Date | 05-04-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 1.89% |
| EPS Growth | ★ 112.50 | 72.73 |
| EPS | 0.15 | ★ 1.99 |
| Revenue | $1,003,782,000.00 | ★ $3,632,118,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $18.19 | $1.34 |
| P/E Ratio | $273.60 | ★ $26.37 |
| Revenue Growth | ★ 28.46 | 26.25 |
| 52 Week Low | $16.61 | $31.55 |
| 52 Week High | $41.14 | $56.48 |
Technical Indicators
Market Signals| Indicator | APLS | VIRT |
|---|---|---|
| Relative Strength Index (RSI) | 84.57 | 53.70 |
| Support Level | $19.29 | $32.61 |
| Resistance Level | $41.14 | $52.18 |
| Average True Range (ATR) | 0.06 | 1.59 |
| MACD | -0.65 | -0.23 |
| Stochastic Oscillator | 58.33 | 42.09 |
Price Performance
Historical ComparisonAbout APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade. Currently it has two marketed drugs that target C3, the central protein in the complement cascade: SYFOVRE (pegcetacoplan injection) and EMPAVELI (pegcetacoplan).
About VIRT Virtu Financial Inc.
Virtu Financial Inc is a financial firm that leverages technology to deliver liquidity to the world-wide markets and transparent trading solutions to its clients. The company's operating segment includes Market Making; and Execution Services. The non-operating segment of the company includes the Corporate segment. The company generates maximum revenue from the market-making segment. The Market Making segment principally consists of market-making in the cash, futures, and options markets across equities, options, fixed income, currencies, and commodities. Geographically, it derives a majority of its revenue from the United States and also has a presence in Ireland and Other Countries.